Metrics In Balance (MLMIB) | Stock Overview & Key Data
Metrics In Balance Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €7.50 on May 13, 2019
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Metrics In Balance MLMIB | 790.30K Small_cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -70.00% | -94.64% | -98.97% |
| Bastide le Confort BLC | 223.19M Mid-cap | -0.16% | 12.37% | 26.69% | 33.33% | 35.32% | 57.88% | -2.88% | -17.29% |
| Laboratoires ALEMG | 12.05M Small-cap | -0.22% | 21.72% | 28.98% | 0.89% | 3.42% | 3.42% | -13.22% | -50.76% |
| bioMérieux S.A BIM | 14.19B Large-cap | 1.45% | -1.65% | 3.66% | 13.01% | 15.87% | 24.36% | 12.40% | -10.04% |
| Eurofins Scientific ERF | 10.59B Large-cap | -1.81% | 1.95% | 26.63% | 23.82% | 22.37% | 22.97% | -23.56% | 7.84% |
| Ipsen S.A IPN | 8.36B Large-cap | -0.19% | -0.77% | 3.93% | -12.17% | -8.75% | -8.15% | 9.51% | 29.01% |
Ownership & Short Interest
Metrics In Balance Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Metrics In Balance would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Metrics In Balance reached a high of €0.10 (on July 23, 2024) and a low of €0.03 (on July 7, 2025).
Curious about Metrics In Balance's size and valuation? Its market capitalization stands at 790.30K. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
As for dividends, Metrics In Balance isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Metrics In Balance, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Bastide le Confort
BLC223.19M Healthcare Medical Distribution 57.88% -2.88% Laboratoires
ALEMG12.05M Healthcare Medical Distribution 3.42% -13.22% bioMérieux S.A
BIM14.19B Healthcare Diagnostics & Research 24.36% 12.40% Eurofins Scientific
ERF10.59B Healthcare Diagnostics & Research 22.97% -23.56% Ipsen S.A
IPN8.36B Healthcare Drug Manufacturers - Specialty & Generic -8.15% 9.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of Metrics In Balance's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.45%, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
Looking at Metrics In Balance's growth, its revenue over the trailing twelve months (TTM) was €300. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Metrics In Balance stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.